{Van Den Eertwegh}, Alfons J M: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line

Saskia J. A. M. Santegoets, Marco W. J. Schreurs, Allan J. Masterson, Ying Poi Liu, Steffen Goletz, Hans Baumeister, Esther W. M. Kueter, Sinéad M. Lougheed, Alfons J. M. van den Eertwegh, Rik J. Sche

Journal:

Cancer Immunology, Immunotherapy

Year:

2006

Language:

english

File:

PDF, 391 KB

english, 2006

2

Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma

Jeffrey S. Weber, Hassan Zarour, Bruce Redman, Uwe Trefzer, Steven O'Day, Alfons J. M. van den Eertwegh, Ernest Marshall, Stefan Wagner

Journal:

Year:

2009

Language:

english

File:

PDF, 242 KB

english, 2009

3

Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophages revisited

Alfons J. M. van den Eertwegh, Jon D. Laman, Marc M. Schellekens, Wim J. A. Boersma, Eric Claassen

Journal:

European Journal of Immunology

Year:

1992

Language:

english

File:

PDF, 931 KB

english, 1992

4

CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia

Johan W. Molling, Tanja D. de Gruijl, Judith Glim, Maria Moreno, Lawrence Rozendaal, Chris J.L.M. Meijer, Alfons J.M. van den Eertwegh, Rik J. Scheper, Mary E. von Blomberg, Hetty J. Bontkes

Journal:

International Journal of Cancer

Year:

2007

Language:

english

File:

PDF, 291 KB

english, 2007

5

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

Inge S. van Houdt, Berbel J.R. Sluijter, Laura M. Moesbergen, Wim M. Vos, Tanja D. de Gruijl, Barbara G. Molenkamp, Alfons J.M. van den Eertwegh, Erik Hooijberg, Paul A.M. van Leeuwen, Chris J.L.M. Me

Journal:

International Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 296 KB

english, 2008

6

Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases

Johan W. Molling, María Moreno, Jan de Groot, Hans J.J. van der Vliet, B. Mary E. von Blomberg, Alfons J.M. van den Eertwegh, Rik J. Scheper, Hetty J. Bontkes

Journal:

Immunology Letters

Year:

2008

Language:

english

File:

PDF, 591 KB

english, 2008

7

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

Tanja D. de Gruijl, Alfons J. M. van den Eertwegh, Herbert M. Pinedo, Rik J. Scheper

Journal:

Cancer Immunology, Immunotherapy

Year:

2008

Language:

english

File:

PDF, 311 KB

english, 2008

8

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

Axel Bex, Astrid A. M. van der Veldt, Christian Blank, Alfons J. M. van den Eertwegh, Epie Boven, Simon Horenblas, John Haanen

Journal:

World Journal of Urology

Year:

2009

Language:

english

File:

PDF, 399 KB

english, 2009

9

Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib

Laura Vroling, Astrid A. M. van der Veldt, Richard R. de Haas, John B. A. G. Haanen, Gerrit Jan Schuurhuis, Dirk J. Kuik, Hester van Cruijsen, Henk M. W. Verheul, Alfons J. M. van den Eertwegh, Klaas

Journal:

Year:

2009

Language:

english

File:

PDF, 343 KB

english, 2009

10

Targeted therapies in renal cell cancer: recent developments in imaging

Astrid A. M. van der Veldt, Martijn R. Meijerink, Alfons J. M. van den Eertwegh, Epie Boven

Journal:

Targeted Oncology

Year:

2010

Language:

english

File:

PDF, 563 KB

english, 2010

11

New developments in autologous tumor cell vaccination therapy for renal cell carcinoma

Alfons JM van den Eertwegh, Herbert M. Pinedo

Journal:

Current Oncology Reports

Year:

2000

Language:

english

File:

PDF, 140 KB

english, 2000

12

Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer

Astrid A.M. van der Veldt, Laura Vroling, Richard R. de Haas, Pieter Koolwijk, Alfons J.M. van den Eertwegh, John B.A.G. Haanen, Victor W.M. van Hinsbergh, Henk J. Broxterman, Epie Boven

Journal:

International Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 1.34 MB

english, 2012

13

In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells

María Moreno, Johan W. Molling, Silvia von Mensdorff-Pouilly, René H.M. Verheijen, B. Mary E. von Blomberg, Alfons J.M. van den Eertwegh, Rik J. Scheper, Hetty J. Bontkes

Journal:

Clinical Immunology

Year:

2008

Language:

english

File:

PDF, 932 KB

english, 2008

14

Invariant natural killer T cells and immunotherapy of cancer

Johan W. Molling, María Moreno, Hans J.J. van der Vliet, Alfons J.M. van den Eertwegh, Rik J. Scheper, B. Mary E. von Blomberg, Hetty J. Bontkes

Journal:

Clinical Immunology

Year:

2008

Language:

english

File:

PDF, 541 KB

english, 2008

15

Attenuation of invariant Natural Killer T-cell anergy induction through intradermal delivery of α-galactosylceramide

Hetty J. Bontkes, María Moreno, Basav Hangalapura, Jelle J. Lindenberg, Jan de Groot, Sinéad Lougheed, Hans J.J. van der Vliet, Alfons J.M. van den Eertwegh, Tanja D. de Gruijl, B. Mary E. von Blomber

Journal:

Clinical Immunology

Year:

2010

Language:

english

File:

PDF, 970 KB

english, 2010

16

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection

Famke L. Schneiders, Rik J. Scheper, B. Mary E. von Blomberg, Andrea M. Woltman, Harry L.A. Janssen, Alfons J.M. van den Eertwegh, Henk M.W. Verheul, Tanja D. de Gruijl, Hans J. van der Vliet

Journal:

Clinical Immunology

Year:

2011

Language:

english

File:

PDF, 624 KB

english, 2011

17

Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity

Johan W. Molling, Maria Moreno, Hans J.J. van der Vliet, B. Mary E. von Blomberg, Alfons J.M. van den Eertwegh, Rik J. Scheper, Hetty J. Bontkes

Journal:

Journal of Immunological Methods

Year:

2007

Language:

english

File:

PDF, 830 KB

english, 2007

18

Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15

Hans J.J van der Vliet, Nobusuke Nishi, Yasuhiko Koezuka, B.Mary E von Blomberg, Alfons J.M van den Eertwegh, Steven A Porcelli, Herbert M Pinedo, Rik J Scheper, Giuseppe Giaccone

Journal:

Journal of Immunological Methods

Year:

2001

Language:

english

File:

PDF, 297 KB

english, 2001

19

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

Charlotte M Huijts, Saskia J Santegoets, Alfons J van den Eertwegh, Laura S Pijpers, John B Haanen, Tanja D de Gruijl, Henk M Verheul, Hans J van der Vliet

Journal:

Year:

2011

Language:

english

File:

PDF, 244 KB

english, 2011

20

In vivo T-B cell interactions and cytokine-production in the spleen

Alfons J.M. van den Eertwegh, Jon D. Laman, Randolph J. Noelle, Wim J.A. Boersma, Eric Claassen

Journal:

Seminars in Immunology

Year:

1994

File:

PDF, 658 KB

1994

21

Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)

María Moreno, Berber M. Mol, Silvia von Mensdorff-Pouilly, René H.M. Verheijen, B.Mary E. von Blomberg, Alfons J.M. van den Eertwegh, Rik J. Scheper, Hetty J. Bontkes

Journal:

Year:

2008

Language:

english

File:

PDF, 149 KB

english, 2008

22

The immunoregulatory role of CD1d-restricted natural killer T cells in disease

Hans J.J van der Vliet, Johan W Molling, B.Mary E von Blomberg, Nobusuke Nishi, Wendy Kölgen, Alfons J.M van den Eertwegh, Herbert M Pinedo, Giuseppe Giaccone, Rik J Scheper

Journal:

Clinical Immunology

Year:

2004

Language:

english

File:

PDF, 393 KB

english, 2004

23

Circulating Vα24+Vβ11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients

Hans J.J. van der Vliet, Johan W. Molling, B. Mary E. von Blomberg, Wendy Kölgen, Anita G. Stam, Tanja D. de Gruijl, Chris J. Mulder, Harry L.A. Janssen, Nobusuke Nishi, Alfons J.M. van den Eertwegh,

Journal:

Clinical Immunology

Year:

2005

Language:

english

File:

PDF, 284 KB

english, 2005

24

Immunomodulation of the melanoma sentinel lymph node: A novel adjuvant therapeutic option

Barbara G. Molenkamp, Paul A.M. van Leeuwen, Alfons J.M. van den Eertwegh, Berbel J.R. Sluijter, Rik J. Scheper, Sybren Meijer, Tanja D. de Gruijl

Journal:

Year:

2006

Language:

english

File:

PDF, 348 KB

english, 2006

25

Metastatic Renal Cell Cancer in a 20-Year-Old Pregnant Woman

Astrid A.M. van der Veldt, Merian van Wouwe, Alfons J.M. van den Eertwegh, R. Jeroen A. van Moorselaar, Herman P. van Geijn

Journal:

Year:

2008

Language:

english

File:

PDF, 146 KB

english, 2008

26

Reply

Astrid A.M. van der Veldt, Merian van Wouwe, Alfons J.M. van den Eertwegh, R. Jeroen A. van Moorselaar, Herman P. van Geijn

Journal:

Year:

2008

Language:

english

File:

PDF, 48 KB

english, 2008

27

Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine

Basav N. Hangalapura, Dinja Oosterhoff, Tarun Gupta, Jan de Groot, Pepijn G.J.T.B. Wijnands, Victor W. van Beusechem, Joke den Haan, Thomas Tüting, Alfons J.M. van den Eertwegh, David T. Curiel, Rik J

Journal:

Year:

2011

Language:

english

File:

PDF, 719 KB

english, 2011

28

CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation

Joana G. Brandão, Rik J. Scheper, Sinéad M. Lougheed, David T. Curiel, Bryan W. Tillman, Winald R. Gerritsen, Alfons J.M. van den Eertwegh, Herbert M. Pinedo, Hidde J. Haisma, Tanja D. de Gruijl

Journal:

Year:

2003

Language:

english

File:

PDF, 159 KB

english, 2003

29

Aggressive combination therapy to cure patients with metastatic cancer

Herbert M Pinedo, Alfons JM van den Eertwegh

Journal:

The Lancet Oncology

Year:

2000

Language:

english

File:

PDF, 53 KB

english, 2000

30

Natural Killer T cells

Hans JJ van der Vliet, Herbert M Pinedo, B Mary E von Blomberg, Alfons JM van den Eertwegh, Rik J Scheper, Giuseppe Giaccone

Journal:

The Lancet Oncology

Year:

2002

Language:

english

File:

PDF, 803 KB

english, 2002

31

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Alfons JM van den Eertwegh, Jurjen Versluis, H Pieter van den Berg, Saskia JAM Santegoets, R Jeroen A van Moorselaar, Tim M van der Sluis, Helen E Gall, Thomas C Harding, Karin Jooss, Israel Lowy, Her

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 306 KB

english, 2012

32

Randomized placebo controlled phase I/II trial of α-galactosylceramide for the treatment of chronic hepatitis C

Bart J. Veldt, Hans J.J. van der Vliet, B. Mary E. von Blomberg, Hans van Vlierberghe, Guido Gerken, Nobusuke Nishi, Kunihiko Hayashi, Rik J. Scheper, Robert J. de Knegt, Alfons J.M. van den Eertwegh,

Journal:

Journal of Hepatology

Year:

2007

Language:

english

File:

PDF, 170 KB

english, 2007

33

Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage

Hans J.J. van der Vliet, B.Mary E. von Blomberg, Nobusuke Nishi, Martine Reijm, Alexandre E. Voskuyl, Ad A. van Bodegraven, Chris H. Polman, Thomas Rustemeyer, Paul Lips, Alfons J.M. van den Eertwegh,

Journal:

Clinical Immunology

Year:

2001

Language:

english

File:

PDF, 61 KB

english, 2001

34

Synthetic peptide conjugates with horseradish peroxidase and β-galactosidase for use in epitope-specific immunocytochemistry and ELISA

Jon D. Laman, Alfons J.M. van den Eertwegh, Carla Deen, Nicole Vermeulen, Wim J.A. Boersma, Eric Claassen

Journal:

Journal of Immunological Methods

Year:

1991

Language:

english

File:

PDF, 3.13 MB

english, 1991

35

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

Revicki, Dennis A, van den Eertwegh, Alfons JM, Lorigan, Paul, Lebbe, Celeste, Linette, Gerald, Ottensmeier, Christian H, Safikhani, Shima, Messina, Marianne, Hoos, Axel, Wagner, Samuel, Kotapati, Sri

Journal:

Health and Quality of Life Outcomes

Year:

2012

Language:

english

File:

PDF, 273 KB

english, 2012

36

IL-21 promotes the expansion of CD27+CD28+tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells

Santegoets, Saskia JAM, Turksma, Annelies W, Suhoski, Megan M, Stam, Anita GM, Albelda, Steve M, Hooijberg, Erik, Scheper, Rik J, van den Eertwegh, Alfons JM, Gerritsen, Winald R, Powell, Daniel J, Ju

Journal:

Journal of Translational Medicine

Year:

2013

Language:

english

File:

PDF, 441 KB

english, 2013

37

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)

Kelderman, Sander, van der Kooij, Monique K., van den Eertwegh, Alfons J. M., Soetekouw, Patricia M. M. B., Jansen, Rob L. H., van den Brom, Rob R. H., Hospers, Geke A. P., Haanen, John B. A. G., Kapi

Journal:

Acta Oncologica

Year:

2013

Language:

english

File:

PDF, 110 KB

english, 2013

38

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Kwon, Eugene D, Drake, Charles G, Scher, Howard I, Fizazi, Karim, Bossi, Alberto, van den Eertwegh, Alfons J M, Krainer, Michael, Houede, Nadine, Santos, Ricardo, Mahammedi, Hakim, Ng, Siobhan, Maio,

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 469 KB

english, 2014

39

Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer: Results of a Compassionate Use Program in The Netherlands

Wissing, Michel D., van Oort, Inge M., Gerritsen, Winald R., van den Eertwegh, Alfons J.M., Coenen, Jules L.L.M., Bergman, Andries M., Gelderblom, Hans

Journal:

Clinical Genitourinary Cancer

Year:

2013

Language:

english

File:

PDF, 582 KB

english, 2013

40

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment

Badrising, Sushil, van der Noort, Vincent, van Oort, Inge M., van den Berg, H. Pieter, Los, Maartje, Hamberg, Paul, Coenen, Jules L., van den Eertwegh, Alfons J. M., de Jong, Igle J., Kerver, Emile D.

Journal:

Year:

2014

Language:

english

File:

PDF, 184 KB

english, 2014

41

New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?

van Dodewaard-de Jong, Joyce M., Verheul, Henk M.W., Bloemendal, Haiko J., de Klerk, John M.H., Carducci, Michael A., van den Eertwegh, Alfons J.M.

Journal:

Clinical Genitourinary Cancer

Year:

2015

Language:

english

File:

PDF, 1.45 MB

english, 2015

42

[18F]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells

Oprea-Lager, Daniela E., van Kanten, Mitchell P., van Moorselaar, Reindert J. A., van den Eertwegh, Alfons J. M., van de Ven, Peter M., Bijnsdorp, Irene V., Hoekstra, Otto S., Geldof, Albert A.

Journal:

Molecular Imaging and Biology

Year:

2015

Language:

english

File:

PDF, 1.16 MB

english, 2015

43

A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems

Oprea-Lager, Daniela E., Yaqub, Maqsood, Pieters, Indra C., Reinhard, Rinze, van Moorselaar, Reindert J. A., van den Eertwegh, Alfons J. M., Hoekstra, Otto S., Lammertsma, Adriaan A., Boellaard, Ronal

Journal:

Molecular Imaging and Biology

Year:

2015

Language:

english

File:

PDF, 1.89 MB

english, 2015

44

Functional characterization of a STAT3-dependent dendritic cell-derived CD14 + cell population arising upon IL-10-driven maturation

Lindenberg, Jelle J., van de Ven, Rieneke, Lougheed, Sinéad M., Zomer, Anoek, Santegoets, Saskia JAM, Griffioen, Arjan W., Hooijberg, Erik, van den Eertwegh, Alfons J.M., Thijssen, Victor L., Scheper,

Journal:

Year:

2013

Language:

english

File:

PDF, 1.40 MB

english, 2013

45

Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition

Oosterhoff, Dinja, Lougheed, Sinéad, van de Ven, Rieneke, Lindenberg, Jelle, van Cruijsen, Hester, Hiddingh, Lotte, Kroon, Jan, van den Eertwegh, Alfons J.M., Hangalapura, Basav, Scheper, Rik J., de G

Journal:

Year:

2012

Language:

english

File:

PDF, 961 KB

english, 2012

46

CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel

Wissing, Michel D., Coenen, Jules L.L.M., van den Berg, Pieter, Westgeest, Hans M., van den Eertwegh, Alfons J.M., van Oort, Inge M., Bos, Monique M., Bergman, André M., Hamberg, Paul, ten Tije, Alber

Journal:

International Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 526 KB

english, 2015

47

Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma

Lindenberg, Jelle J, van de Ven, Rieneke, Oosterhoff, Dinja, Sombroek, Claudia C, Lougheed, Sinéad M, Stam, Anita GM, Koenen, Hans JPM, van den Eertwegh, Alfons JM, Scheper, Rik J, de Gruijl, Tanja D

Journal:

Human Vaccines & Immunotherapeutics

Year:

2014

Language:

english

File:

PDF, 1.70 MB

english, 2014

48

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

Santegoets, Saskia, Stam, Anita, Lougheed, Sinéad M, Gall, Helen, Jooss, Karin, Sacks, Natalie, Hege, Kristen, Lowy, Israel, Scheper, Rik J, Gerritsen, Winald R, van den Eertwegh, Alfons, de Gruijl, T

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2014

Language:

english

File:

PDF, 734 KB

english, 2014

49

Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review

Jong, Joyce M. van Dodewaard-de, Oprea-Lager, Daniela E., Hooft, Lotty, de Klerk, John M.H., Bloemendal, Haiko J., Verheul, Henk M.W., Hoekstra, Otto S., van den Eertwegh, Alfons J.M.

Journal:

European Urology

Year:

2015

Language:

english

File:

PDF, 932 KB

english, 2015

50

Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF transduced allogeneic prostate cancer cells

van Dodewaard-de Jong, Joyce M., Santegoets, Saskia J.A.M., van de Ven, Peter M., Versluis, Jurjen, Verheul, Henk M.W., de Gruijl, Tanja D., Gerritsen, Winald R., van den Eertwegh, Alfons J.M.

Journal:

Year:

2015

Language:

english

File:

PDF, 2.71 MB

english, 2015

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски